Teneobio - Ownership and Business Overview

Life ScienceCompany

Teneobio Ownership

Who owns Teneobio?

Teneobio is owned by Amgen. It was acquired on July 27, 2021.

Teneobio Business Overview

Where is Teneobio headquartered?

Teneobio is headquartered in Newark, California.

What sector is Teneobio in?

Teneobio is a life science company.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 392 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 346 by strategics.

Teneobio

Teneobio, Inc.

7999 Gateway Boulevard,
Newark, California 94560
United States,
(650) 899-8200
www.teneobio.com

Teneobio is a clinical-stage biotechnology company developing a new class of biologics, Human Heavy-Chain Antibodies (UniAb), for the treatments of cancer, autoimmunity, and infectious diseases. Teneobio's discovery platform, TeneoSeek, comprises genetically engineered animals (UniRat and OmniFlic), next-generation sequencing, bioinformatics, and high-throughput vector assembly technologies. TeneoSeek rapidly identifies large numbers of unique binding molecules specific for therapeutic targets of interest. Versatile antibody variable domains (UniDab) derived from UniAb can be assembled into multi-specific and multivalent therapeutic proteins, surpassing the limitations of conventional antibody therapeutics. Teneobio is based in Newark, California.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.